Public Consultation on the Post-Market Review of Products Used in the Management of Diabetes Stage 3: Medicines Used in the Management of Type 2 Diabetes

Page last updated: 29 May 2015

Stakeholder Forum Outcomes

The Stakeholder Forum was held in Canberra on 12 September 2013 for Stage 3 of the Diabetes Review: Medicines Used in the Management of type 2 diabetes.

The Forum provided a further opportunity for stakeholders to contribute to Stage 3 of the Review. The Forum summary is now available for viewing:

Stakeholder Forum Summary for Stage 3 of the Diabetes Review on Medicines Used in the Management of type 2 diabetes (Word 88KB) - (PDF 455KB).
 

Public Submissions

The Call for Submissions closed on 2 July 2013.

The Department appreciates the contribution of all organisations and individuals who made a submission.

Unless otherwise requested, all submissions to the Review have been published below.

The Department of Health has not published submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.

Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.

All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.

More information on the Review is available at Post-market Review of Post-market Review of Products Used in the Management of Diabetes. If you have difficulty accessing the information provided and need further assistance, please send an email to the Review Secretariat.

Disclaimer

• The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
• The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
• The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquiries and assessments about those matters or seek independent advice.
• Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.
• The Commonwealth reserves the right not to publish a submission or part of a submission that it considers defamatory or otherwise inappropriate for publication.

 

List of Submissions

Submission	Author Name	Document link	Date Received
1	GlaxoSmithKline Australia	Not for publication	20/06/2013
2	Individual Professional	Submission 2 (PDF 359 KB)	24/06/2013
3	Australian Medical Association	Submission 3 (PDF 76 KB)	25/06/2013
4	Royal Australian College of General Practitioners	Submission 4 (PDF 841 KB)	01/07/2013
5	Eli Lilly Australia	Submission 5 (PDF 590 KB)	01/07/2013
6	Individual Professional	Submission 6 (PDF 467 KB)	02/07/2013
7	Pharmaceutical Society of Australia	Submission 7 (PDF 340 KB)	02/07/2013
8	Boehringer Ingelheim	Submission 8 (PDF 119 KB)	02/07/2013
9	Servier Laboratories	Submission 9 (PDF 333 KB)	02/07/2013
10	Novo Nordisk	Submission 10 (PDF 409 KB)	02/07/2013
11	MediMark International	Submission 11 (PDF 1166 KB)	02/07/2013
12	Australian Diabetes Educators Association	Not for publication	02/07/2013
13	Diabetes Australia	Submission 13 (PDF 400 KB)	02/07/2013
14	Bristol Myers Squibb + AstraZeneca	Submission 14 (PDF 1029 KB)	02/07/2013
15	Merck Sharp and Dohme	Not for publication	02/07/2013
16	Sanofi	Submission 16 (PDF 502 KB)	02/07/2013
17	Individual Professional	Submission 17 (PDF 91 KB)	02/07/2013
18	The Pharmacy Guild of Australia	Submission 18 (PDF 625 KB)	02/07/2013
19	Australian Diabetes Council	Submission 19 (PDF 396 KB)	02/07/2013
20	Individual Professional	Not for publication	02/07/2013
21	The Australian Centre for Behavioural Research in Diabetes	Submission 21 (PDF 467 KB)	02/07/2013
22	Janssen Australia Pty Ltd	Submission 22 (PDF 118 KB)	02/07/2013
23	Medicines Australia	Submission 23 (PDF 1050 KB)	02/07/2013
24	Consumers Health Forum of Australia	Submission 24 (PDF 1265 KB)	02/07/2013
25	Other Government Organisation	Not for publication	08/07/2013

The documents on this page may not be accessible. If you need help please email the Review Secretariat.